Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption? - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue BMC Infectious Diseases Année : 2014

Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?

Résumé

We explored the impact of transient cART started during the primary HIV-infection (PHI) on the long-term immunologic and virologic response on cART resumption, by comparison with treatment initiation during the chronic phase of HIV infection (CHI). We analyzed data on 1450 patients enrolled during PHI in the ANRS PRIMO cohort between 1996 and 2013. "Treatment resumption" was defined as at least 3 months of resumed treatment following interruption of at least 1 month of treatment initiated during PHI. "Treatment initiation during CHI" was defined as cART initiated ≥6 months after PHI. The virologic response to resumed treatment and to treatment initiated during CHI was analyzed with survival models. The CD4 cell count dynamics was modeled with piecewise linear mixed models. 136 patients who resumed cART for a median (IQR) of 32 (18-51) months were compared with 377 patients who started cART during CHI for a median of 45 (22-57) months. Most patients (97%) achieved HIV-RNA <50 cp/mL after similar times in the two groups. The CD4 cell count rose similarly in the two groups during the first 12 months. However, after 12 months, patients who started cART during CHI had a better immunological response than those who resumed cART (p = 0.01); therefore, at 36 months, the gains in √CD4 cells/mm(3) and CD4% were significantly greater in patients who started treatment during CHI. These results suggest that interruption of cART started during PHI has a significant, albeit modest negative impact on CD4 cell recovery on cART resumption.
Fichier principal
Vignette du fichier
s12879-015-0892-1.pdf (611.06 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-01187356 , version 1 (26-08-2015)

Identifiants

Citer

Evguenia Krastinova, Rémonie Seng, Jérôme Lechenadec, Henri Panjo, Asma Essat, et al.. Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?. BMC Infectious Diseases, 2014, 15 (1), pp.178. ⟨10.1186/s12879-015-0892-1⟩. ⟨inserm-01187356⟩
302 Consultations
1156 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More